Sort
53,477 grants matching “addiction”
Characterizing brain dynamic biomarkers of fentanyl using intracranial and high-density electroencephalogram in humans
$743,289Patrick L. Purdon · Massachusetts General Hospital · R01 · FY2022 · DA
Parallel Multimodal High-throughput screening to identify activators of the orexin receptors
$743,268Theodore M Kamenecka · Scripps Florida · R01 · FY2019 · MH
mHealth to Enhance & Sustain Drug Use Reduction of the QUIT BI in Primary Care
$743,262Lillian Gelberg · University Of California Los Angeles · R01 · FY2021 · DA
A Structural Intervention to Improve Substance Abuse Diagnosis and Treatment Practices in HIV Clinic Settings
$743,195Ana Maria Ventuneac · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · DA
Cannabinergic Medications for Methamphetamine Addiction
$743,185Alexandros Makriyannis · Northeastern University · R37 · FY2016 · DA
Early Stress, Sensitive Periods and the Neurobiology of Addiction
$743,157Martin H Teicher · Mclean Hospital · R01 · FY2012 · DA
Strengthening Research Collaborations in Health Disparities
$743,046Cheryl Davenport Dozier · Savannah State University · P20 · FY2011 · MD
Strengthening Research Collaborations in Health Disparities
$743,046Cheryl Davenport Dozier · Savannah State University · P20 · FY2012 · MD
RCT of tDCS-Augmented CBT for Veterans with Pain and Opioid Misuse
$743,010Jeffrey J Borckardt · Medical University Of South Carolina · R01 · FY2017 · DA
Transcriptomic single-cell profiling in breathing-specific parabrachial mu-opioid receptor neurons
$742,953Sung Han · Salk Institute For Biological Studies · R01 · FY2022 · DA
Transcriptomic single-cell profiling in breathing-specific parabrachial mu-opioid receptor neurons
$742,953Sung Han · Salk Institute For Biological Studies · R01 · FY2023 · DA
Transition to Nicotine Dependence in Adolescence
$742,947Columbia University Health Sciences · R01 · FY2001 · DA
BD2K product for enhancing phenotypic screens
$742,912Jennifer Fuller · Genecentrix, Inc. · R44 · FY2019 · DA
Long-Term Abstinence Clinical Issues and CNS Disinhibition
$742,843George Fein · Neurobehavioral Research, Inc. · R01 · FY2012 · AA
RCT of an Integrated Treatment of Persons with Co-Occurring HCV and Alcohol Abuse
$742,809Rae Jean Elizabeth Proeschold-Bell · Duke University · R01 · FY2017 · AA
Better Outcomes for Children: Promoting Excellence in Healthcare Genomics to Inform Policy
$742,762John Barker Harley · Cincinnati Childrens Hosp Med Ctr · U01 · FY2019 · HG
FMRI Dynamic Phantom for Improved Detection of Resting-State Brain Networks
$742,748Alan Kriegstein · Ala Scientific Instruments, Inc. · R44 · FY2018 · DA
HIV Infection, Cocaine Use and Coronary Artery Disease in HIV+ African Americans
$742,699Shenghan Lai · Johns Hopkins University · R01 · FY2008 · DA
PRECLINICAL MEDICATIONS DISCOVERY & ABUSE LIABILITY TESTING FOR NIDA
$742,626Louis S. Harris · Virginia Commonwealth University · N01 · FY2014 · DA
UAB Outcomes of Babies with Opioid Exposure (OBOE study)
$742,500Namasivayam Ambalavanan · Research Triangle Institute · PL1 · FY2019 · HD
Evaluating New Nicotine Standards for Cigarettes - Project 1
$742,453Dorothy K Hatsukami · Wake Forest University Health Sciences · U54 · FY2022 · DA
EXTENDED CASE MONITORING FOR ALCOHOLICS : HEALTH COSTS
$742,386Pacific Institute For Res And Evaluation · R01 · FY2003 · AA
NPQ/Spexin the Endogenous Ligand for the Galanin Receptor 3
$742,361Lawrence R Toll · Torrey Pines Inst For Molecular Studies · R01 · FY2016 · DA
Blood Donor Competence, Autonomy and Relatedness Enhancement (Blood Donor CARE)
$742,267Christopher R France · Ohio University Athens · R01 · FY2019 · HL
Changing our paths: Well-being and recovery among American Indians with opioid use disorder
$742,203Brenna Greenfield · University Of Minnesota · R61 · FY2020 · DA